Solana (SOL) has been showing some interesting patterns lately.
Based on recent analysis, Solana is currently in a bullish trend, with its price testing key resistance levels.
Here are a few points to consider:
Trendline Analysis:
Solana has been following an upward-sloping trendline, which is a positive sign for potential buyers. As long as it stays above this trendline, the bullish momentum is likely to continue.
Support and Resistance Levels: ...

The Dow Jones Industrial Average (Dow) recently experienced its worst performance since 1978, falling for nine consecutive days, causing concern. On Tuesday, the Dow fell by 267.58 points, closing at 43449.90 points, a decrease of 0.61%. Meanwhile, the S&P 500 Index and the Nasdaq Composite Index also saw significant declines of 0.39% and 0.32% respectively. This trend has drawn widespread market attention, especially with the backdrop of the Federal Reserve's upcoming interest rate decision.
The main reason for this round of decline is the shift of funds towards technology stocks, triggering the selling of traditional economic sector stocks. These traditional stocks had performed strongly in November, but the current market sentiment shows investors are feeling uneasy about the future economic outlook. Despite a slight uptick of 0.15% in the technology sector index, newcomers to the Dow like NVIDIA are facing correction pressure, indicating market confidence in tech stocks is not stable.
David Russell, TradeStation's Global Market Strategy Director, stated that the market is gradually realizing that some events are not as favorable for the stock market as investors hoped. The strong performance of financial and industrial sector stocks since early November might now be impacted by higher interest rates and trade uncertainty. Additionally, the healthcare sector is facing significant risks, adding more uncertainty to the market.
As the Federal Reserve is about to hold an interest rate meeting, market expectations for interest rate policies are heating up again. According to the FedWatch tool of the CME Group...